Cargando…
MicroRNA regulation of AMPK in nonalcoholic fatty liver disease
Obesity-associated nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and is the leading cause of liver failure and death. The function of AMP-activated protein kinase (AMPK), a master energy sensor, is aberrantly reduced in NAFLD, but the underlying mechanisms are not...
Autores principales: | Sun, Hao, Kemper, Jongsook Kim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545736/ https://www.ncbi.nlm.nih.gov/pubmed/37653034 http://dx.doi.org/10.1038/s12276-023-01072-3 |
Ejemplares similares
-
Obesity-induced miR-802 directly targets AMPK and promotes nonalcoholic steatohepatitis in mice
por: Sun, Hao, et al.
Publicado: (2022) -
MicroRNAs in Nonalcoholic Fatty Liver Disease
por: Baffy, György
Publicado: (2015) -
MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Fang, Zhiqiang, et al.
Publicado: (2021) -
MicroRNA-137-3p Improves Nonalcoholic Fatty Liver Disease through Activating AMPKα
por: Yu, Yuanjie, et al.
Publicado: (2021) -
Transgenic mice lacking FGF15/19-SHP phosphorylation display altered bile acids and gut bacteria, promoting nonalcoholic fatty liver disease
por: Kim, Young-Chae, et al.
Publicado: (2023)